SARS-CoV-2 vaccine (Immunethep)

N/A

Report date: 2025/01/26 15:33:31

Base Information

Drug NameSARS-CoV-2 vaccine (Immunethep)

Drug Alias Nameinactivated vaccine (Immunethep)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyVaccines > Development/production technology > Inactivated vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPortugal

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmunethep SA

China Registration ClassN/A

Develop Information

Active CompaniesImmunethep SA

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A